The bill amends the Public Safety Officers’ Benefits (PSOB) provisions in the Omnibus Crime Control and Safe Streets Act of 1968 to establish a presumption that exposure-related cancers constitute personal injuries sustained in the line of duty for purposes of death and permanent-total-disability claims. It supplies a defined list of cancers, creates a mechanism for adding cancers based on competent medical evidence, and explains when the presumption does not apply.
Separately, the bill widens confidentiality protections for information furnished to components of the Office of Justice Programs, makes those confidentiality rules effective retroactively to 1979, and includes several technical edits (including an expanded definition of “line of duty action” in the Safeguarding America’s First Responders Act). The changes create new administrative responsibilities for the Bureau and affect claim filing deadlines and evidentiary standards for PSOB claims tied to cancer-related conditions.
At a Glance
What It Does
Adds subsection (p) to section 1201 to treat exposure to listed carcinogens as a presumed line-of-duty personal injury that can support PSOB death or permanent-disability payments, subject to specific service and timing thresholds and a medical-evidence exception. It requires the Bureau director to review and update the list at least every 3 years and to accept petitions to add cancers with specified review timelines.
Who It Affects
Survivors and disabled public safety officers (law enforcement, firefighters, EMS) seeking PSOB benefits, the Bureau/Office of Justice Programs (which will administer the new presumptions and update process), and parties seeking access to OJP-held information (which becomes more broadly confidential).
Why It Matters
The bill shifts evidentiary burden toward claimants by creating statutory presumptions tied to occupational exposure, potentially accelerating benefits while increasing program payouts. At the same time, retroactive confidentiality and rulemaking duties raise implementation, transparency, and budget questions for DOJ and federal appropriators.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The core change is a new subsection in the PSOB statute that defines “exposure-related cancer” through a fixed list of malignancies and any cancer later added through an administrative update. The statutory list names common cancers (for example, bladder, lung, leukemia, mesothelioma, prostate, thyroid, and others) and explicitly imports World Trade Center–related cancers recognized under the Public Health Service Act.
By statute, exposure to a listed carcinogen is presumptively a line-of-duty personal injury that may support a death or permanent-total-disability claim, but the presumption can be rebutted by competent medical evidence showing the exposure was not a substantial contributing factor.
To limit overbreadth, the bill attaches three objective triggers to the presumption: the exposure must have occurred during line-of-duty action; the officer must have served at least five years before diagnosis; and the cancer diagnosis must occur within 15 years of the officer’s last active service. The director of the Bureau must review the cancer definition at least every three years and can update the list either by rule or by public notice.
Individuals and organizations can petition to add cancers, and the bill sets a 180-day referral timeline for expert review plus a 30-day congressional notification requirement when substantive actions follow a recommendation.The measure applies retroactively in two ways. First, it authorizes claims tied to qualifying deaths or disabilities occurring on or after January 1, 2020, and permits claimants affected by the statutory change to file within three years of enactment even if earlier filing deadlines would otherwise bar them.
Second, the bill broadens confidentiality of information furnished to any Office of Justice Programs component and makes that confidentiality effective for all purposes as if it had been enacted on December 27, 1979, and applicable to pending matters.Finally, the bill cleans up two technical items: it amends cross-references to include subsection (b) in an existing section of the PSOB provisions, and it expands the statutory definition of “line of duty action” in the Safeguarding America’s First Responders Act to include actions performed at an agency’s direction or that the officer is authorized or obligated to perform. That definitional change is also made applicable to claims tied to events on or after January 1, 2020, with the same three-year post-enactment filing window for affected claimants.
The Five Things You Need to Know
The bill adds subsection (p) to 34 U.S.C. 10281 and lists specific cancers that qualify as “exposure-related cancers,” while permitting later additions through an administrative update process.
To trigger the presumption an officer must have at least 5 years of service before diagnosis and the cancer must be diagnosed within 15 years of last active service; the presumption is rebuttable if competent medical evidence shows exposure was not a substantial contributing factor.
The Bureau Director must review the cancer list at least once every 3 years, and any person may petition to add cancers; petitions must be referred to medical experts within 180 days and substantive agency action triggers a 30-day notice to the House and Senate Judiciary Committees.
The bill broadens confidentiality of information furnished to Office of Justice Programs components and makes that confidentiality effective retroactively to December 27, 1979, applying to pending matters.
For claimants affected by these changes, the bill creates a 3‑year window after enactment during which they may file claims tied to qualifying cancer deaths or disabilities that occurred on or after January 1, 2020.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Designates the measure as the "Honoring Our Fallen Heroes Act of 2025." This is purely a caption but signals congressional intent and helps identify the act in appropriations and administrative guidance.
Defines 'exposure-related cancer,' 'carcinogen,' and 'Director'
Establishes statutory terms used by the new presumption. 'Carcinogen' requires an IARC Group 1 or 2A classification and a reasonable link to occupational exposure. The cancer list includes 22 named cancers and any cancers added through the update process; it also incorporates cancers recognized as WTC-related under the Public Health Service Act. These definitional choices set the scientific baseline for administrative determinations and the scope of compensable conditions.
Creates a rebuttable presumption that exposure to listed carcinogens is a line-of-duty personal injury
Makes exposure to a listed carcinogen presumptively a line-of-duty injury for death or permanent-total-disability claims, subject to four eligibility criteria (line-of-duty exposure, ≥5 years of service before diagnosis, diagnosis within 15 years of last active service, and causation to death or disability). The presumption is rebuttable when competent medical evidence establishes the exposure was not a substantial contributing factor, preserving an evidentiary escape hatch for agencies or the Bureau when causation is demonstrably absent.
Imposes a regular review cycle and a formal petition path to add cancers
Requires the Bureau director to reassess the cancer list at least every 3 years and authorizes updates by rule or public notice. It allows any person to petition for additions; petitions must include competent medical evidence and receive expert referral within 180 days. The director must consider expert recommendations and notify the House and Senate Judiciary Committees within 30 days after taking substantive action. This creates predictable administrative timelines but embeds medical judgment into a benefits statute.
Expands confidentiality of OJP-held information and makes it retroactive
Alters 34 U.S.C. 10231(a) to broaden what information is protected from disclosure — covering information furnished under any law to any Office of Justice Programs component and identifying both the furnishing entity and the person the information concerns. The amendment is effective as if enacted in 1979 and applies to pending matters, meaning a large volume of historical records could be treated as confidential under these revised terms.
Makes technical edits to cross-references and defines 'line of duty action'
Adjusts cross-references in section 1201(o)(2) to include subsection (b), preventing misapplication of procedural rules. Separately, it amends the Safeguarding America’s First Responders Act to define 'line of duty action' to include actions an officer undertakes at an agency’s direction or actions the officer is authorized or obligated to perform; this broader definition is made applicable to claims back to January 1, 2020, subject to the same 3-year filing window after enactment.
This bill is one of many.
Codify tracks hundreds of bills on Justice across all five countries.
Explore Justice in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Surviving spouses and dependents of public safety officers whose deaths are tied to listed cancers — the statutory presumption should speed PSOB death benefit determinations and reduce evidentiary hurdles.
- Public safety officers with qualifying disabilities — those who become permanently and totally disabled due to a listed cancer will find it easier to establish a line-of-duty injury for PSOB disability benefits.
- Unions, advocacy groups, and claimants’ counsel — the presumption and a formal petition process give organized advocates clear levers to expand coverage for additional cancers based on medical evidence.
Who Bears the Cost
- The Bureau/Office of Justice Programs and DOJ — they must establish and maintain the medical review and rulemaking infrastructure, adjudicate more presumptive claims, and handle petition workflows and notifications.
- Federal PSOB funding and ultimately taxpayers — broader presumptions and expanded eligibility will increase benefit outlays unless Congress appropriates offsetting funds or tightens other eligibility elements.
- Researchers, media, and oversight entities — the retroactive expansion of confidentiality may reduce access to historical OJP-held records used for independent analysis, litigation, or oversight, potentially shifting costs to parties seeking records through alternate legal channels.
Key Issues
The Core Tension
The central dilemma is between simplifying and honoring access to benefits for officers with occupational cancers—by shifting the evidentiary burden via presumptions—and preserving rigorous causation standards, fiscal restraint, and public transparency; the bill leans toward expedited relief for claimants at the cost of higher program liability, greater administrative burden, and reduced external scrutiny of OJP-held information.
The bill trades a clear social objective—easing access to benefits for officers with occupationally related cancers—for several practical frictions. First, the statutory presumption lowers the claimant’s burden but gives the Bureau and defendants a narrow path to rebuttal based on 'competent medical evidence' that exposure was not a substantial contributing factor.
That standard is legally meaningful but factually demanding; it will shift disputes into medical expert contests rather than straightforward administrative denials or approvals. Second, the required science-driven update and petition process anchors benefit scope to evolving research, but implementing expert review panels, referral procedures, and notice obligations will require new procedures, staff, and funding at DOJ.
The retroactive confidentiality amendment is consequential and potentially controversial in implementation. Treating decades of OJP information as confidential could block FOIA-based access to records that researchers, journalists, or litigants currently use to study occupational risks, program administration, or past adjudications.
That retroactivity also raises litigation risk, as parties who previously relied on access may litigate asserted loss of rights or seek narrow carve-outs. Finally, the bill leaves budget mechanics unspecified: it expands potential liabilities for the PSOB program but does not include appropriations or an offset.
Agencies will need guidance from DOJ and the Treasury on funding and on how the 3-year post-enactment filing window interacts with statutes of limitation in other contexts.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.